Kerecis ehf Pipeline Insight and Therapeutic Assessment Reviewed in 2017

Market Research HUB Market Research HUB

Albany, US, 2017-Nov-30 — /EPR Network/ —:  Kerecis ehf is a medical device company” that provides products that treats chronic wounds and damaged tissue. The companys flagship Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic and oral wounds, for dura mater repair, breast reconstruction and abdominal wall reconstruction and for surgical stapling. It also develops mOmega3 fatty acid (fish-sourced fatty acids) technology for use in several dermatological indications such as psoriasis, eczema, dermatitis, keratosis pilaris and pseudofolliculitis.

Request For Free Sample – 

Kerecis major products consists of fish-skin acellular dermal matrix products such as Omega3 Wound, Omega3 Dura, Omega3 Hernia, Omega3 Pectus, Omega3 Seal, and topical creams including Smooth with mOmega3, Footguard with mOmega3, Psoria with mOmega3 and Xma with mOmega3. The company uses complete acellular fish skin for tissue regeneration by transplantation. Kerecis is headquartered in Isafjordur, Iceland.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


– The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
– The report analyzes all pipeline products in development for the company Kerecis ehf
– The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
– The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
– The report provides detailed description of products in development, technical specification and functions
– The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

– Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
– Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
– To formulate effective Research & Development strategies
– Develop market-entry and market expansion strategies
– Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
– Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Browse Full Report With TOC –

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Kerecis ehf Company Overview 4
Kerecis ehf Company Snapshot 4
Kerecis ehf Pipeline Products and Ongoing Clinical Trials Overview 5
Kerecis ehf Pipeline Analysis Overview 7

Kerecis ehf – Key Facts 7
Kerecis ehf – Major Products and Services 8
Kerecis ehf Pipeline Products by Development Stage 9
Kerecis ehf Pipeline Products Overview 11
Kerecis Omega3 Dura 11
Kerecis Omega3 Dura Product Overview 11
Kerecis Omega3 Hernia 12
Kerecis Omega3 Hernia Product Overview 12

Kerecis Omega3 Pectus 13
Kerecis Omega3 Pectus Product Overview 13
Kerecis Omega3 Wound 14
Kerecis Omega3 Wound Product Overview 14
Kerecis ehf – Key Competitors 15

Kerecis ehf – Key Employees 16
Kerecis ehf – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Kerecis ehf, Recent Developments 18
Mar 22, 2017: PolyMedics Innovations to Sell Kerecis Omega3-rich Fish-Skin Burn Treatment in the U.S. 18
Oct 18, 2016: Kerecis Omega3-rich Fish-Skin Treatment for Wound Treatment to be Introduced to the Asian Market at a Major Medical Congress in Singapore 18
Sep 16, 2016: Kerecis Wound-Treatment Product With Omega3 Fish Skin Now Eligible for Medicare Reimbursement in 45


Enquire About this Report –

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.


Contact Us

90 State Street,

Albany, NY 12207,

United States

Toll Free : 800-998-4852 (US-Canada)

Email :

Website :

Read Industry News at –

Matched content

Editor’s pick

Express Press Release Distribution